Application 202514
- Type
- NDA
- Sponsor
- OAK PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZIOPTAN | TAFLUPROST | SOLUTION/DROPS;OPHTHALMIC | 0.0015% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17478-609 | ZIOPTAN | tafluprost | Akorn, Inc. | NDA | Current |
| 17478-609 | ZIOPTAN | tafluprost | Akorn, Inc. | NDA | Current |
| 17478-609 | ZIOPTAN | tafluprost | Akorn | NDA | Current |
| 17478-609 | ZIOPTAN | tafluprost | Akorn, Inc. | NDA | Current |
| 17478-609 | ZIOPTAN | tafluprost | Akorn | NDA | Current |
| 17478-609 | ZIOPTAN | tafluprost | Akorn, Inc. | NDA | Current |
| 66993-429 | Tafluprost Ophthalmic | tafluprost | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 82584-609 | ZIOPTAN | Tafluprost | Thea Pharma Inc. | NDA | Current |